Search for: "JANSSEN PHARMA V APOTEX"
Results 1 - 20
of 25
Sorted by Relevance
|
Sort by Date
16 Apr 2012, 9:49 pm
By Andrew Williams -- On Monday, in Dey Pharma, LP v. [read post]
18 Sep 2008, 8:58 pm
In Janssen Pharma v. [read post]
6 May 2007, 9:06 pm
Apotex Oxycontin: Purdue Pharma v. [read post]
30 Dec 2009, 2:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
2 Jul 2007, 2:51 pm
Teva Risperdal: Janssen Pharmaceutica et al. v. [read post]
19 Dec 2008, 1:00 pm
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360) Fentora… [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog)… [read post]
2 Apr 2007, 9:52 pm
Apotex OxyContin: Purdue Pharma v. [read post]
23 Jun 2009, 9:46 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
11 Jan 2011, 11:07 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
10 Feb 2010, 4:47 pm
Aurobindo Pharma Ltd. et al. [read post]
15 Dec 2010, 2:17 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Jul 2009, 5:15 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
3 Apr 2009, 4:50 am
: Scinopharm Taiwan Ltd v Eli Lily & Co (PatLit) Naglazyme (Galsulfase) - Brazil: Federal Court of the First Region orders government to supply unapproved drug Naglazyme (IP tango) Plavix (Clopidogrel) – US: Bristol-Myers Squibb to pay $2.1 million to settle FTC claims it issues misleading statement about proposed Plavix patent deal with Apotex, violating court orders from earlier anti-trust cases (Law360) Razadyne (Galantamine) – US: Johnson &… [read post]
11 Jul 2008, 4:30 am
: (Spicy IP), India: Ranbaxy-Daiichi deal – Opportunities for private equity companies in India: (Profitability through Simplicity), India: (KEI) Cracking open anti-competitive practices in the developing world: complaints, amendments and waivers: (Spicy IP), India: Is it one rule for Indian pharma companies and another one for those from abroad? [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper… [read post]
